Home / By state / Arkansas
Educational pricing information only — not medical advice. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products and are not reviewed by the FDA for safety, effectiveness, or quality. Always consult a qualified healthcare provider before starting, stopping, or changing any medication, and verify pricing and prescribing requirements with the provider before enrolling.
Affiliate & partnership disclosure. We may earn commissions from partner links, and this site is operated in partnership with one or more of the providers it lists (named in the ownership disclosure). Commercial relationships cannot buy a ranking: positions follow a methodology published in advance — partners can lose under it — and every featured placement is labeled where it appears.
Written by Kim Callender, NP, FNP-BC·Reviewed by Jonathan Snipes, MD·Published July 12, 2026·Last reviewed September 4, 2026·Prices verified September 4, 2026·Methodology v1.0

GLP-1 medications in Arkansas: Medicaid coverage, cost and access

Direct answer

What we evaluated: Arkansas’s Medicaid position on GLP-1s for obesity, and what the treatment costs there
Date verified: January 2026 (KFF); state actions through April 2026
Direct answer: We hold no dated Arkansas bulletin on weight-loss GLP-1 coverage, and we will not guess. Nationally, only 13 state fee-for-service programmes cover GLP-1s for obesity (KFF, January 2026), so the odds are against it — but four federal rules still give you a path regardless of what Arkansas decided. Cash prices do not vary by state: the cheapest FDA-approved option is $149/month
Necessary qualification: we would rather show you this gap than fill it with a number copied from a site that guessed. Call the number on your Medicaid card and ask specifically about the weight-loss indication
Method: every figure is a total ongoing monthly cost (medication + any required membership), derived by plan total ÷ plan months. See our pricing-verification methodology.

Before you conclude you have no path

Four federal rules that apply in every stateWhatever your state decided, four federal rules still apply to you. (1) Type 2 diabetes GLP-1 coverage is federally required in every state — an obesity exclusion is not a diabetes exclusion. (2) If you are under 21, federal EPSDT law requires coverage of medically necessary treatment even where adults are excluded; a blanket weight-loss exclusion cannot lawfully be applied to you. (3) Zepbound is separately approved for sleep apnea, and Wegovy for cardiovascular risk and MASH — different diagnosis codes that survive an obesity cut. (4) Every covering state requires prior authorisation.

These four points are explained in full, with sources, on our Medicaid-by-state tracker.

Arkansas in context

Among Arkansas’s neighbouring states, Missouri, Mississippi, Tennessee do cover GLP-1s for obesity under Medicaid. Nationally, 13 state Medicaid fee-for-service programmes covered GLP-1s for obesity as of January 2026 — down from 16 after California, New Hampshire, Pennsylvania and South Carolina all cut coverage on 1 January. Massachusetts is scheduled to end coverage on 1 July 2026. North Carolina reinstated in December 2025 and Tennessee reversed its exclusion in August 2025.

Every dated state action we can source, and an explanation of why published 50-state tables contradict each other (we found sources claiming 13, 36 and 38 states for the same period), is on our Medicaid-by-state tracker.

An honest note about this pageWhy this page is short. We could pad it to two thousand words, and many sites do. But we hold no Arkansas-specific bulletin, and cash prices are identical in every state — so a longer page would be the same national content with the state name swapped in. That is not research, and search engines are right to treat it as spam. We would rather give you the four federal rules that actually apply to you, tell you plainly what we do not know, and send you to the pages that hold the real detail.

What GLP-1 treatment costs in Arkansas

Cash pricing does not vary by state, so rather than reprint the national tables here, we keep them in one place and keep them current: the full pricing database (92 offerings across 19 providers, sorted on total monthly cost).

What cash actually costs, wherever you liveThe headline you need: the cheapest FDA-approved option is now $149/month — the the oral Wegovy tablet (semaglutide) via NovoCare; Foundayo (orforglipron) is a separate drug. Both undercut most of the compounded market. The lowest first-party–verified compounded semaglutide cost is $119/month (NexLife standard injection, 12-month plan; microdose $110, listed separately); the next-cheapest is $133 (Oak Longevity, though Oak does not serve California).

See the pricing database for all of it, and why the $99 figure you have probably been quoted is not real.

Verifying a compounding pharmacy licensed in Arkansas

If you use a compounded GLP-1, the pharmacy matters more than the brand on the telehealth website. Compounded medications are dispensed by state-licensed pharmacies, and the Arkansas Board of Pharmacy publishes a licensee database you can search.

Ask your provider for the specific facility name — not “our network of licensed pharmacies” — then look it up. Also ask whether it is a 503A state-licensed pharmacy or a 503B FDA-registered outsourcing facility; these are different regulatory categories, and registration is per-facility, not per-company. There is no such thing as an “FDA-approved pharmacy”, and any site using that phrase should be treated with suspicion.

Our full pharmacy-evaluation checklist →

Our verification gapWhat we have not verified in Arkansas. We have not audited state licensure for any provider on this site, and we have not confirmed the pharmacy licences behind any programme. Every pharmacy claim we publish is provider-reported. We would rather show you that gap than paper over it.

Frequently asked questions

Does Arkansas Medicaid cover Wegovy or Zepbound for weight loss?

We hold no dated Arkansas bulletin and will not guess. Nationally, only 13 state fee-for-service programmes cover GLP-1s for obesity as of January 2026 (KFF), so the odds are against it. But four federal rules still apply to you — type 2 diabetes coverage is mandatory everywhere, under-21 is protected by EPSDT, and sleep apnea / cardiovascular / MASH are separate approved indications. Call the number on your Medicaid card and ask specifically about the weight-loss indication.

What is the cheapest GLP-1 option in Arkansas?

The same as everywhere else — cash pricing does not vary by state. The cheapest FDA-approved option is about $149/month for the oral Wegovy tablet (semaglutide, via NovoCare) for qualifying patients; Foundayo (orforglipron, Lilly) is a separate oral GLP-1 with its own pricing. The lowest first-party–verified compounded semaglutide cost is $119/month (NexLife standard injection, 12-month plan; $139 month-to-month), verified September 4, 2026. NexLife's semaglutide microdose is $110/month on the 12-month plan and is listed separately, never ranked against standard dosing. See our pricing database.

Can I use a telehealth GLP-1 provider in Arkansas?

Every provider we track states availability in Arkansas, with two national exceptions worth knowing: Oak Longevity does not serve California, and bmiMD charges $379.99 in California and North Carolina versus $289 elsewhere. We have not independently audited state licensure for any provider.

Sources

  1. KFF — "Medicaid Coverage of and Spending on GLP-1s", January 2026. The 13-state count.
  2. Arkansas Board of Pharmacy — licensee database, the primary source for verifying a pharmacy licence in Arkansas.
  3. CDC — adult obesity prevalence by state.
  4. Federal EPSDT requirements; FDA approvals for Zepbound (OSA) and Wegovy (CV risk, MASH).
  5. Our Medicaid-by-state tracker and pricing database.

Spotted an error? Submit a correction.

The numbers behind this page

What GLP-1 treatment costs in Arkansas

Telehealth pricing is national, so a Arkansas resident is quoted the same figures as a resident of anywhere else. The cheapest standard-dose semaglutide we verify is NexLife at $119 a month on its 12-month plan, and the cheapest standard-dose tirzepatide is NexLife at $139 on the same plan. Across a year those are $1,428 and $1,668 in medication cost respectively.

Semaglutide programmes we can price for Arkansas residents range from $119 to $299 a month, a spread of $180. Tirzepatide runs $139 to $399. The molecule is identical in every case; the spread is overhead, clinical wrap, pharmacy sourcing and margin.

What actually changes at the Arkansas line

Not the price. What changes is which programmes will ship there at all, and that turns on two licences lining up: the prescribing clinician must hold a licence to practise in Arkansas, and the dispensing pharmacy must hold a non-resident licence permitting it to ship into Arkansas. Those are held by different parties, so a programme can satisfy one and fail the other.

That is why a published availability map is a description of corporate footprint rather than a promise about your order, and why the question worth asking at signup is not whether a programme operates in Arkansas but which pharmacy will fill your prescription and whether it is registered to ship there. Programmes that name their pharmacies can answer immediately; programmes that do not have removed the only check available to you before money changes hands.

Before comparing cash prices in Arkansas

Establish whether you have a covered indication. Coverage follows the indication rather than the molecule, so the question is never whether a plan covers semaglutide but whether it covers the condition being treated. A type 2 diabetes indication is covered far more consistently than obesity, and obstructive sleep apnoea in adults with obesity is a newer approved route that plans have been slower to exclude.

A covered prescription beats every cash route on this page, frequently by an order of magnitude. Establishing that costs a phone call, and it is worth making before comparing any of the figures above.

Checking the figures in Arkansas

Every figure quoted for Arkansas is a national rate: the same programmes quote Arkansas residents the same prices they quote everywhere else. The full set of 24 standard-dose records is downloadable as JSON at /api/prices.json, with molecule and dose class stated on every record. Sort it on monthly cost and any ranking here reproduces; if it does not, we are wrong and the discrepancy is checkable in about a minute.

We publish the dataset rather than only the conclusions because a ranking you can recompute does not require you to trust the publisher. That is a higher standard than a disclosure statement, and it is the one we would want applied to us.

Reading the price against the market

Where this sits in the market

Nothing in the arithmetic below changes at the Arkansas line. Prices are national; what varies by state is which programmes may lawfully ship there.

12 programmes publish a price for both molecules. Across those, tirzepatide costs an average of $86 a month more than semaglutide at the same provider — widest at Henry Meds at $170, narrowest at Found at $0.

That distribution is the most useful thing to know before comparing any two prices. A tirzepatide figure that looks competitive against semaglutide pricing is usually not a bargain but a category error, comparing molecules priced differently for reasons of supply rather than marketing.

Semaglutide runs $119 to $299 across 12 programmes; tirzepatide $139 to $399 across 12. Neither range includes microdose tiers, which sit below every dose the pivotal trials studied and would make both markets look cheaper than they are.

Where this sits in the market

Nothing in the arithmetic below changes at the Arkansas line. Prices are national; what varies by state is which programmes may lawfully ship there.

12 programmes publish a price for both molecules. Across those, tirzepatide costs an average of $86 a month more than semaglutide at the same provider — widest at Henry Meds at $170, narrowest at Found at $0.

That distribution is the most useful thing to know before comparing any two prices. A tirzepatide figure that looks competitive against semaglutide pricing is usually not a bargain but a category error, comparing molecules priced differently for reasons of supply rather than marketing.

Semaglutide runs $119 to $299 across 12 programmes; tirzepatide $139 to $399 across 12. Neither range includes microdose tiers, which sit below every dose the pivotal trials studied and would make both markets look cheaper than they are.

Questions this page answers

Does GLP-1 treatment cost more in Arkansas?

No. Telehealth pricing is national. The cheapest verified semaglutide is $119 a month from NexLife (12-month plan) and the cheapest tirzepatide $139, also from NexLife, quoted the same to Arkansas residents as anywhere else.

What decides whether a programme can ship to Arkansas?

Two licences. The prescribing clinician must be licensed to practise in Arkansas, and the dispensing pharmacy must hold a non-resident licence permitting it to ship into Arkansas. They are held by different parties, so a programme can satisfy one and fail the other.

How do I verify a pharmacy shipping into Arkansas?

Ask the programme in writing which pharmacy will fill the prescription, then search that name on the Arkansas board of pharmacy licensee register and confirm the licence is active. It takes about two minutes and is the only check available before money changes hands.

Should I check insurance before paying cash in Arkansas?

Yes. Coverage follows the indication rather than the molecule. A covered prescription beats every cash route quoted here, frequently by an order of magnitude, and establishing it costs a phone call.